- A company acquires two assets: goodwill from a business combination and a patent with a 10-year useful life. Assuming no impairment indicators for the patent during the year, what is the key difference in their subsequent accounting treatment at the end of the first year?
Answer: The patent is amortized, while goodwill is not amortized but must be tested for impairment.
Goodwill is the archetypal indefinite-life intangible asset and is never amortized under U.S. GAAP. Instead, it must be tested for impairment at least annually. A patent is a finite-life intangible asset and must be amortized over its useful life (10 years). It is only tested for impairment if there is a triggering event. Since the problem states there are no impairment indicators for the patent, no impairment test is needed for it in the first year. Thus, the patent is amortized, and goodwill is tested for impairment.
- SoftwarePlus Corporation has entered into three different intellectual property arrangements: (1) an exclusive licensing agreement to use patented technology for 15 years with an option to renew for additional 15-year terms at fair market value, (2) a franchise agreement granting territorial rights for 25 years with automatic renewal provisions unless either party provides 2-year notice, and (3) a software development platform with a perpetual license but requiring mandatory upgrades every 4 years that cost 60% of the original platform price. The technology under arrangement (1) typically becomes obsolete every 8-10 years. Which useful life classification is most defensible?
Answer: Licensing agreement: finite-life (8-10 years); Franchise: indefinite-life; Software platform: finite-life (4 years)
The licensing agreement should be finite-life (8-10 years) based on economic obsolescence, which is shorter than the legal term. The franchise should be indefinite-life because automatic renewal with only notice requirements creates no foreseeable limit. The software platform should be finite-life (4 years) because mandatory upgrades at 60% of original cost represent substantial economic barriers. Choice A incorrectly treats the software platform as indefinite-life. Choice B uses legal terms instead of economic factors and misclassifies the franchise. Choice D incorrectly treats the licensing agreement as indefinite-life despite obsolescence issues.
- MedTech Industries holds three intangible assets: (1) a patent on a medical device with 8 years remaining legal life but expected to generate cash flows for only 6 years due to competitive pressure, (2) a government license to operate that expires in 15 years but can be renewed indefinitely for nominal fees with no substantive barriers, and (3) a customer list purchased from a competitor that has no legal protection but is expected to provide benefits for 4 years. Which classification is most appropriate?
Answer: Patent: finite-life (6 years); License: indefinite-life due to renewable nature; Customer list: finite-life (4 years)
The patent is finite-life based on the shorter of legal (8 years) or economic (6 years) life. The license is indefinite-life because it can be renewed indefinitely with no substantive barriers. The customer list is finite-life (4 years) based on expected benefit period, regardless of lack of legal protection. Choice A incorrectly uses legal life for the patent and misclassifies the customer list. Choice C incorrectly treats the patent as indefinite-life. Choice D uses wrong useful life for the patent and incorrectly classifies the customer list as indefinite-life.
- RetailMax acquired three customer-related intangible assets: (1) a customer database with detailed purchasing histories spanning 10 years, legally protected by privacy agreements for 5 years, with expected customer relationships lasting 8 years based on industry analysis, (2) customer loyalty program points liability of $500,000 representing future obligations to customers, and (3) a customer acquisition system with proprietary algorithms having no legal protection but providing competitive advantages expected to last 6 years before requiring major updates. How should the useful lives be determined?
Answer: Database: 5 years; Loyalty points: not an intangible asset; Acquisition system: 6 years
The customer database should use 5 years (shortest of legal protection, which limits the asset's exclusive value). Loyalty points represent a liability, not an intangible asset, so useful life determination is not applicable. The acquisition system should use 6 years based on expected economic benefits despite lack of legal protection. Choice A incorrectly treats loyalty points as an intangible asset. Choice B uses economic life instead of legal constraint for the database and incorrectly classifies the acquisition system as indefinite-life. Choice D uses data span instead of legal protection period and incorrectly treats loyalty points as an intangible asset.
- A controller is reviewing a newly acquired government license. The license grants exclusive rights to operate in a specific region for 5 years. It is renewable for subsequent 5-year periods. The renewal process is not automatic and requires a formal application and regulatory approval, which is dependent on the company's past compliance and public service record. Historically, the regulator has denied renewals for approximately 10% of applicants. How should the controller classify the license?
Answer: As a finite-life intangible with a life of 5 years because the renewal is not substantially certain.
For a renewable intangible asset to be classified as indefinite-life, renewal must be reasonably expected without significant cost or uncertainty. The fact that renewal is subject to regulatory approval and that there is a historical rate of denial (10%) introduces significant uncertainty. This uncertainty creates a foreseeable limit on the asset's life, making a finite-life classification over the initial 5-year term the most appropriate choice.
- In the context of intangible assets, the term 'indefinite life' signifies that the asset's life is:
Answer: Not limited by any legal, regulatory, contractual, or economic factors, but is not necessarily infinite.
This question tests the precise definition of 'indefinite.' 'Indefinite' does not mean 'infinite.' It means that there is no foreseeable limit on the period of time over which the asset is expected to generate net cash inflows. The useful life could be very long, but an unexpected event could curtail it in the future. The key is the absence of any current limiting factors, whether legal, economic, or otherwise.
- GlobalBrand Inc. acquired a competitor and obtained the following intangibles: a trademarked product name that can be renewed every 15 years for $50,000 (current market value of similar trademarks is $2 million), exclusive distribution rights for a specific territory lasting 8 years with no renewal option, and a non-compete agreement preventing the former owner from competing for 3 years. The trademark has been successfully renewed twice previously. Which combination of classifications is correct?
Answer: Trademark: indefinite-life; Distribution rights: finite-life; Non-compete: finite-life
The trademark is indefinite-life because renewal costs ($50,000) are nominal compared to the asset's value ($2 million), and successful past renewals indicate no barriers to continued renewal. Distribution rights are finite-life (8 years) with no renewal option. The non-compete agreement is finite-life (3 years) by its terms. Choice B incorrectly treats the trademark as finite-life and distribution rights as indefinite-life. Choice C incorrectly classifies both trademark and non-compete. Choice D incorrectly treats the non-compete as indefinite-life.
- Which of the following statements presents the most accurate conceptual distinction between accounting for finite-life and indefinite-life intangible assets?
Answer: The cost of finite-life intangibles is allocated systematically to expense over time, whereas the cost of indefinite-life intangibles is not.
The core conceptual difference lies in cost allocation. The cost of a finite-life intangible asset is systematically allocated to expense (amortized) over its estimated useful life to match the cost with the revenues it helps generate. In contrast, an indefinite-life intangible asset is not amortized because there is no foreseeable limit to its useful life, making systematic allocation impossible. Its value is maintained on the balance sheet until impairment is identified.
- TechnoFlow Corporation acquired a customer database for $2.4 million. The database contains proprietary algorithms and customer preferences that are legally protected for 12 years. However, due to rapid technological changes in the industry, the company estimates the database will become obsolete within 5 years. Additionally, TechnoFlow holds a trademark for its brand name, which has no legal expiration but requires renewal fees every 10 years. How should these intangible assets be classified and initially measured?
Answer: Database: finite-life (5 years), $2.4M; Trademark: indefinite-life, at cost including renewal fees
The database should be classified as finite-life based on the shorter of legal life (12 years) or economic useful life (5 years), so 5 years controls. The trademark should be classified as indefinite-life because it can be renewed indefinitely with no foreseeable limit, and renewal fees are part of the cost to maintain the asset. Choice B incorrectly uses legal life over economic life for the database. Choice C incorrectly classifies the database as indefinite-life and the trademark as finite-life. Choice D incorrectly treats the trademark as finite-life.
- A pharmaceutical company acquires a patent for a new drug. The patent has a remaining legal life of 17 years. However, a more effective competing drug is expected to enter the market in 6 years, at which point the company projects that sales of its patented drug will become negligible. How should the company account for the patent's cost?
Answer: Amortize the cost over 6 years, as this represents the asset's useful economic life.
For a finite-life intangible asset like a patent, amortization should occur over its useful life. The useful life is the shorter of the legal life and the economic life. In this case, the economic life (6 years) is shorter than the legal life (17 years) due to expected technological obsolescence from a competing product. Therefore, the cost should be amortized over the 6-year period.
- An analyst observes that a company with a large, unamortized intangible asset balance on its balance sheet has just experienced a significant, sustained downturn in its stock price and market capitalization. This situation should raise the analyst's concern about a potential overstatement of the company's earnings primarily because:
Answer: The downturn may indicate that the fair value of an indefinite-life intangible is below its carrying amount, requiring an impairment loss.
A large, unamortized intangible asset balance suggests the presence of indefinite-life intangibles (like goodwill or trademarks). These are not amortized but must be tested for impairment annually and when triggering events occur. A significant decline in stock price and market capitalization is a key indicator that the fair value of such assets may have fallen below their carrying value. This would necessitate recognizing an impairment loss, which directly reduces earnings. The concern is not a lack of amortization (A, D) but an unrecorded impairment loss.
- BioPharma Inc. acquired rights to three different pharmaceutical-related assets: (1) FDA approval for a drug compound valid indefinitely but subject to safety reviews every 7 years that could result in withdrawal, with historical withdrawal rates of 15% per review cycle, (2) exclusive manufacturing rights to a biosimilar drug for 12 years with no renewal option, and (3) a research database containing 20 years of clinical trial data with no legal protection but considered valuable due to the specialized nature of the research and high barriers to replication. The database's usefulness is expected to decline significantly after 10 years due to evolving medical standards. How should these assets be classified?
Answer: FDA approval: finite-life (7 years); Manufacturing rights: finite-life (12 years); Research database: finite-life (10 years)
The FDA approval should be finite-life (7 years) because regular safety reviews with 15% withdrawal rates create a foreseeable limit to the asset's life. Manufacturing rights should be finite-life (12 years) with no renewal option. The research database should be finite-life (10 years) based on expected decline in usefulness due to evolving medical standards, regardless of lack of legal protection. Choice B incorrectly treats FDA approval as indefinite-life despite withdrawal risk and the database as indefinite-life despite declining utility. Choice C incorrectly treats both FDA approval and manufacturing rights as indefinite-life. Choice D incorrectly treats manufacturing rights as indefinite-life despite no renewal option.
- When a company determines that a previously indefinite-life intangible asset now has a finite useful life of 10 years, which of the following is the correct accounting procedure?
Answer: The carrying amount of the asset is tested for impairment, and then amortized over the next 10 years.
A change from an indefinite to a finite life is a change in accounting estimate. It is handled prospectively. The asset's carrying amount is not retroactively adjusted. Instead, the company begins to amortize the current carrying amount over the new, finite useful life (10 years). Critically, the events or circumstances that lead to this change in useful life also require the asset to be tested for impairment. Thus, an impairment test is performed first, any loss is recognized, and the (potentially reduced) carrying amount is then amortized prospectively.
- An analyst is comparing two companies in the same industry. Company A's balance sheet shows significant intangible assets, primarily acquired patents and customer lists. Company B's balance sheet also shows significant intangible assets, primarily acquired trademarks and goodwill. Assuming no impairments have occurred, which of the following is the most likely difference an analyst would find in the companies' income statements?
Answer: Company A has a higher amortization expense, leading to lower reported net income than Company B.
Patents and customer lists are typically classified as finite-life intangible assets and are therefore amortized over their useful lives. This creates a regular amortization expense on the income statement. Trademarks and goodwill are typically classified as indefinite-life intangible assets and are not amortized. Therefore, all else being equal, Company A will report amortization expense while Company B will not, resulting in lower reported net income for Company A.
- A company acquires a non-compete agreement with a term of 7 years as part of a business acquisition. Three years later, the individual bound by the agreement passes away, rendering the agreement moot. The unamortized cost of the agreement is $40,000. How should the company account for this event?
Answer: Write off the remaining $40,000 as an expense in the current period.
The non-compete agreement is a finite-life intangible asset. The death of the individual permanently ends any future economic benefit from the agreement. When an asset ceases to have future economic benefit, its carrying amount should be written off. Therefore, the remaining unamortized cost of $40,000 should be recognized as an expense in the current period.
- An analyst reviewing a company's financial statement footnotes finds a disclosure that the company's significant intangible assets are not being amortized. What is the most direct and logical conclusion the analyst can draw from this information alone?
Answer: The company has classified these intangible assets as having indefinite useful lives.
According to U.S. GAAP, intangible assets are either finite-life (and amortized) or indefinite-life (and not amortized). The fact that significant intangible assets are not being amortized directly points to the conclusion that management has classified them as having indefinite useful lives. While other explanations could be possible under specific circumstances, this is the most direct and intended interpretation of the accounting policy.
- A media company acquires a portfolio of internet domain names. One domain is for its primary corporate brand, which it has used for 20 years and intends to use indefinitely. Another is for a specific movie promotion and is expected to attract traffic for only the next 18 months. What is the most appropriate accounting treatment for these assets?
Answer: Capitalize the corporate domain as an indefinite-life asset and the promotional domain as a finite-life asset.
The classification of an intangible asset depends on its expected period of economic benefit, not just its legal form. The corporate brand domain is expected to generate benefits indefinitely and should be classified as such (no amortization, annual impairment test). The promotional domain has a clear, foreseeable limit of 18 months and must be classified as a finite-life asset and amortized over that period. It is incorrect to treat all assets of the same type identically.
- A company acquires a trademark for a popular consumer product. The trademark's registration can be renewed every 10 years at a nominal cost, and the company intends to support the product for the foreseeable future. However, the company's strategic plan includes a product line overhaul, and it is determined that this specific product will be discontinued in exactly 8 years. What is the appropriate accounting for the trademark upon acquisition?
Answer: Classify as a finite-life intangible and amortize its cost over the 8-year period until the product is discontinued.
The useful life of an intangible asset is the shorter of its legal life and its economic life. Although the trademark has a legally indefinite life through renewals, the company's own strategic plan provides a foreseeable limit on the period during which it will generate cash flows (8 years). Therefore, it must be classified as a finite-life intangible and amortized over its 8-year useful economic life.
- TechStart Inc. developed internally and subsequently registered a trademark for $25,000 in legal fees after spending $200,000 on internal development costs. The trademark protection lasts 10 years and can be renewed indefinitely for $1,000 per renewal. The company also purchased a competitor's trade name for $800,000, which has been renewed successfully for 30 years and requires renewal every 12 years at a cost of $75,000, though similar trade names currently sell for $600,000-$900,000. How should these intangible assets be classified and measured?
Answer: Trademark: indefinite-life, $25,000; Trade name: indefinite-life, $800,000
The internally developed trademark should be recorded at $25,000 (only legal costs, as internal development costs are expensed) and classified as indefinite-life due to nominal $1,000 renewal costs. The purchased trade name should be classified as indefinite-life because renewal costs ($75,000) are not significant relative to the asset's value ($800,000), and it has a long history of successful renewal. Choice A incorrectly includes internal development costs and misclassifies the trade name. Choice C treats both as finite-life and includes renewal fees in initial measurement. Choice D includes internal development costs and includes renewal fees in the trade name cost.
- DataStream Corp purchased software licenses under three different agreements: License A has a 10-year term with automatic renewal unless either party objects with 90-day notice, License B has a 5-year term renewable at DataStream's option for successive 5-year periods at market rates, and License C grants perpetual usage rights but requires annual maintenance fees that have increased 15% annually. The software under License C becomes obsolete every 3-4 years typically. How should these licenses be classified for financial reporting purposes?
Answer: License A: indefinite-life; License B: finite-life (5 years); License C: finite-life (3-4 years)
License A is indefinite-life because automatic renewal creates no foreseeable limit unless either party actively objects. License B is finite-life because renewal requires active decision-making and market-rate negotiations each period. License C is finite-life based on economic obsolescence (3-4 years) despite perpetual legal rights, as increasing maintenance costs and technological obsolescence limit useful life. Choice A incorrectly treats all as indefinite-life. Choice B incorrectly treats License A as finite-life. Choice C incorrectly classifies both License A and License B.
